LDL-Cholesterol Is Not the Only Clinically Relevant Biomarker for Coronary Artery Disease or Acute Coronary Syndrome

被引：9

作者：

Field, Patrick A. ^{[1
,2
]}

Vasan, Ramachandran S. ^{[1
,2
,3
,4
,5
,6
]}

机构：

[1] Boston Univ, Boston, MA 02215 USA

[2] NHLBI, Framingham Study, Framingham, MA USA

[3] Boston Univ, Sch Med, Sect Prevent Med & Epidemiol, Dept Epidemiol, Boston, MA 02118 USA

[4] Boston Univ, Sch Med, Sect Cardiovasc Med, Dept Epidemiol, Boston, MA 02118 USA

[5] Boston Univ, Sch Publ Hlth, Sect Prevent Med & Epidemiol, Dept Epidemiol, Boston, MA 02118 USA

[6] Boston Univ, Sch Publ Hlth, Sect Cardiovasc Med, Dept Epidemiol, Boston, MA 02118 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2018年 / 104卷 / 02期

关键词：

CARDIOVASCULAR RISK;

D O I：

10.1002/cpt.1126

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Coronary artery disease (CAD) is a progressive disorder and its risk is best determined using multiple biomarkers and risk factors. Many novel biomarkers have been shown to improve cardiovascular disease risk beyond that of the traditional risk factors, including polygenic risk scores, small very low-density lipoprotein (VLDL), ApoB, triglycerides (TG), non-HDL-c, lipoprotein (a) (Lp(a)), coronary calcium scores, C-reactive protein (CRP), B-type natriuretic peptide (BNP), troponins, and many other novel biomarkers that have been measured using high throughput assays.

引用

页码：232 / 234

页数：3

共 50 条

[41] Correlation between LDL/HDL-cholesterol ratio and long term prognosis after acute coronary syndrome and severity of coronary artery disease
God, M.
Manola, S.
Jurin, I
Novak, A.
Hadzibegovic, I
Pavlovic, N.
Sipic, T.
Pavlov, M.
Blivajs, A.
Udovicic, M.
Lisicic, A.
Zeljkovic, I
EUROPEAN HEART JOURNAL, 2024, 45
[42] Coronary artery disease and acute coronary syndrome in women
Mehilli, Julinda
Presbitero, Patrizia
HEART, 2020, 106 (07) : 487 - 492
[43] Coronary Artery Aneurysmal Disease and Acute Coronary Syndrome
Ostwani, Wesam
Fleming, Holly
Roldan, Carlos A.
JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2016, 4 (01):
[44] Novel risk factors in coronary artery disease: are they clinically relevant?
Tousoulis, Dimitris
HELLENIC JOURNAL OF CARDIOLOGY, 2019, 60 (03) : 149 - 151
[45] Small dense LDL-cholesterol concentrations are more powerful marker than LDL-cholesterol to predict coronary events in stable ischernic heart disease
Koba, S.
Yokota, Y.
Tsunoda, F.
Ban, Y.
Sato, R.
Sato, T.
Suzuki, H.
Geshi, E.
Katagiri, T.
CLINICAL CHEMISTRY, 2006, 52 (06) : A115 - A115
[46] LDL-TRIGLYCERIDES IS A BETTER DISCRIMINATOR BETWEEN PATIENTS WITH AND WITHOUT ANGIOGRAPHICALLY PROVEN CORONARY-ARTERY DISEASE THAN LDL-CHOLESTEROL
WIELAND, H
NAUCK, M
WILHELM, KH
ARTERIOSCLEROSIS, 1988, 8 (05): : A592 - A592
[47] Should we consider low LDL-cholesterol a marker of in-hospital bleeding in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
Gorog, Diana A.
Navarese, Eliano P.
Andreotti, Felicita
EUROPEAN HEART JOURNAL, 2021, 42 (33) : 3187 - 3189
[48] Coronary event secondary prevention with statins irrespective of LDL-cholesterol
Kerst, LL
Mauro, VF
ANNALS OF PHARMACOTHERAPY, 2004, 38 (06) : 1060 - 1064
[49] LDL-cholesterol predicts negative coronary artery remodelling in diabetic patients:: an intravascular ultrasound study
Jiménez-Quevedo, P
Sabaté, M
Angiolillo, D
Alfonso, F
Hernández-Antolín, R
Bañuelos, C
Bernardo, E
Ramirez, C
Moreno, R
Fernández, C
Escaned, J
Macaya, C
EUROPEAN HEART JOURNAL, 2005, 26 (21) : 2307 - 2312
[50] YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease
Wang, Yongzhong
Ripa, Rasmus Sejersten
Johansen, Julia Sidenius
Gabrielsen, Anders
Steinbruchel, Daniel A.
Friis, Tina
Bindslev, Lene
Haack-Sorensen, Mandana
Jorgensen, Erik
Kastrup, Jens
SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2008, 42 (05) : 295 - 302

← 1 2 3 4 5 →